ArticleFrontiers in oncology2026

Transarterial infusion chemotherapy combined with lenvatinib and tislelizumab versus intravenous chemotherapy for unresectable pancreatic ductal adenocarcinoma: a retrospective propensity score matching analysis.

Haohao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.